Latest Oncology Stories
Presentations Including Pivotal Data on Kyprolis® and Blinatumomab, a BiTE® Immunotherapy, Demonstrate Company's Continued Commitment to Developing Treatments for Difficult-to-Treat Blood Cancers THOUSAND
Trial will be one of the first of its kind; based on previous success with immunotherapy for patients with recurring leukemia SEATTLE, Nov.
Cancer survivorship advocate Beth Sanders Moore urges oncologists to recommend mindfulness meditation in the holistic treatment of breast cancer HOUSTON, Nov.
- Note: This release corresponds to ASH abstracts 22, 31, 78, 84, 176, 327, 505, 2096, 2312, 3448, 3474, 4454, 4469, 4680 RARITAN, N.J., Nov.
The Mesothelioma Victims Center is pointing to a new study from Spain that indicates high dose radiation combined with radical surgery for diagnosed victims of mesothelioma added no benefit as
One of the Baldwin Park BP4BC, Auto Detail Supplies Outlet (http://www.autodetailsuppliesoutlet.com), is proud to announce,
MONTREAL, Nov. 3, 2014 /CNW Telbec/ - Prostate cancer remains the most common cancer and the third most common cause of cancer-related deaths in Canadian men.
Bluebeards Original is donating 5% of every purchase made on its website to Lung Cancer Awareness and promoting the cause on its social media sites. EXTON, Pa., Nov.
HOUSTON and CLEVELAND, Nov.